SARTORE BIANCHI, ANDREA

SARTORE BIANCHI, ANDREA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 189 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 2019 Pietrantonio, FilippoSiena, SalvatoreSartore-Bianchi, Andrea + Article (author) -
A molecularly annotated platform of patient- derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 2011 G. MigliardiE. ValtortaA. Sartore BianchiS. Siena + Article (author) -
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin 2020 Pagani, MassimilianoMauri, GianlucaSartore-Bianchi, AndreaAbrignani, SergioSiena, Salvatore + Article (author) -
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer : the 'BRAF BeCool' study 2019 Sartore-Bianchi, AndreaPietrantonio, FilippoSiena, Salvatore + Article (author) -
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 2016 E. ValtortaF. PietrantonioS. SienaA. Sartore-Bianchi + Article (author) -
Acquired resistance to EGFR-targeted therapies incolorectal cancer 2014 A. Sartore BianchiS. Siena + Article (author) -
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 2016 A. Sartore BianchiS. Siena + Article (author) -
Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO) 2022 E. G. PizzutiloA. G. AgostaraS. OrestiL. MazzeoT. BeninatoG. CereaA. Sartore-BianchiS. Siena + Conference Object -
Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutations: Retrospective observational multicenter study (ARTICUNO) 2022 E. G. PizzutiloG. CereaS. OrestiA. G. AgostaraL. MazzeoD. L. CortinovisA. Sartore BianchiS. Siena + Conference Object -
Adaptive mutability of colorectal cancers in response to targeted therapies 2019 Sartore-Bianchi, AndreaSiena, SalvatoreGherardi, MarcoLagomarsino, Marco Cosentino + Article (author) -
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 2022 Ambrosini, MargheritaManca, PaoloRandon, GiovanniSartore-Bianchi, AndreaDi Bartolomeo, MariaPietrantonio, Filippo + Article (author) -
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer 2017 F. PietrantonioA. Sartore-BianchiG. FucàS. SienaF. de Braud + Article (author) -
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer 2013 E. ValtortaA. Sartore BianchiG. MigliardiS. Siena + Article (author) -
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer 2006 A. Sartore BianchiM. MoroniS. Siena + Article (author) -
Application of histology-agnostic treatments in metastatic colorectal cancer 2022 Sartore-Bianchi, AndreaAgostara, Alberto GiuseppePatelli, GiorgioMauri, GianlucaPizzutilo, Elio GregorySiena, Salvatore Article (author) -
Aspirin for colorectal cancer with PIK3CA mutations : the rising of the oldest targeted therapy? 2013 A. Sartore BianchiS. Siena + Article (author) -
Assessment of a HER2 scoring system for colorectal cancer : results from a validation study 2015 A. Sartore BianchiG. VialeS. Siena + Article (author) -
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab 2010 A. Sartore-BianchiS. Siena + Article (author) -
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 2022 Pietrantonio, FilippoSartore-Bianchi, AndreaCorti, FrancescaMauri, Gianluca + Article (author) -
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer 2009 S. SienaSARTORE BIANCHI, ANDREA + Article (author) -